Mounjaro (tirzepatide) and Victoza (liraglutide) are both FDA-approved to treat type 2 diabetes, while Zepbound (tirzepatide) and Saxenda (liraglutide) are FDA-approved specifically for weight loss
S-Acetyl-L-glutathione (6.25 g/g per day), but not GSH, increases survival in a mouse model of HSV-1 infection
Attorneys Office described how in a ruse to avoid FDA scrutiny, the peptides had been labeled for research/laboratory use only. Brunner states that the use of such peptides, which come from unknown and possibly unregulated manufacturers, is risky: For a patient to trust and inject that substance into their body is incredibly dangerous. Even when the active ingredient is safe, DIYers open themselves up to other risks when reconstituting their medicine
The oral route has made it a practical compound for longer-duration studies investigating the chronic consequences of GHS-R1a activation
Interestingly, while microdosing is often used to slow down weight loss and protect muscle, unsupervised dosing without proper nutritional and resistance-training guidance still leaves these high-risk groups in uncharted territory
